TORONTO and GLIL YAM, Israel, April 16, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive right to launch the BLK MKT™ br

TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive right to launch the BLK

KELOWNA, BC, TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 4, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products and IM Cannabis Corp. (CSE:IMCC)(NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, are pleased to announce the signing of an International Trademark Licensing Agreement (the &quo

With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients.

With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients.

TORONTO and GLIL YAM, Israel, March 28, 2024 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended December 31, 2023 and 2022 (the "Annual Financial Statements") and accompanying management's discussion and analysis (the "Annual MD&A") can be acc

TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company's full set of consolidated audited financial statements for the years ended December 31, 2023 and 2022 (the "Annual Financial Statements") and accompanying management's discussion and analysis (the "Annual MD&A") can

Not for distribution to United States newswire services or for dissemination in the United States

TORONTO and GLIL YAM, Israel, Jan. 31, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that it has received a 180 calendar day extension, until July 29, 2024, from the Nasdaq Stock Market ("Nasdaq"), to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Rule").

TORONTO and GLIL YAM, Israel, Jan. 31, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that it has received a 180 calendar day extension, until July 29, 2024, from the Nasdaq Stock Market ("Nasdaq"), to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Rule").

TORONTO and GLIL YAM, Israel, Jan. 12, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the parties regarding the remaining transaction payments are being rescheduled to April 15, 2024.

TORONTO and GLIL YAM, Israel, Jan. 12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the parties regarding the remaining transaction payments are being rescheduled to April 15, 2024.

TORONTO and GLIL YAM, Israel, Jan. 2, 2024 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the construction proceedings against Focus Medical Herbs Ltd. ("Focus Medical"), were concluded on December 28, 2023. The company maintains "de facto" control of Focus Medical. Focus Medical was indicted and a fine of CAD$129,000 has been imposed. The cultivation facility, which was the focus of the proceedings, was closed in June 2022 in alignment with the company's strategic sh

TORONTO and GLIL YAM, Israel, Jan. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the construction proceedings against Focus Medical Herbs Ltd. ("Focus Medical"), were concluded on December 28, 2023. The company maintains "de facto" control of Focus Medical. Focus Medical was indicted and a fine of CAD$129,000 has been imposed. The cultivation facility, which was the focus of the proceedings, was closed in June 2022 in alignment with the company's strat

TORONTO and GLIL YAM, Israel, Nov. 27, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Investments Ltd. (collectively the "MYM Shareholder Plaintiffs") against IMC Cannabis Corp. and its board of directors and officers, (collectively, "IMC"). A copy of this complaint was delivered to IMC on November 17, 2023.

TORONTO and GLIL YAM, Israel, Nov. 27, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Investments Ltd. (collectively the "MYM Shareholder Plaintiffs") against IMC Cannabis Corp. and its board of directors and officers, (collectively, "IMC"). A copy of this complaint was delivered to IMC on November 17, 2023.

IMC remains singularly focused on accelerating its path to profitability through active cost management and margin improvement while maintaining sales.

IMC remains singularly focused on accelerating its path to profitability through active cost management and margin improvement while maintaining sales.

TORONTO and GLIL YAM, Israel, Nov. 8, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens.

TORONTO and GLIL YAM, Israel, Nov. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens.

TORONTO and GLIL YAM, Israel, Oct. 13, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany releases message from Chief Executive Officer about the Israel-Hamas War and announces the Company, through its wholly-owned subsidiaries, IMC Holdings Ltd. ("IMC HoldCo") and Rosen High Way Ltd. ("Rosen High Way"), has secured C$1,390,000 in short-term debt.

TORONTO and GLIL YAM, Israel, Oct. 13, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany releases message from Chief Executive Officer about the Israel-Hamas War and announces the Company, through its wholly-owned subsidiaries, IMC Holdings Ltd. ("IMC HoldCo") and Rosen High Way Ltd. ("Rosen High Way"), has secured C$1,390,000 in short-term debt.

TORONTO and GLIL YAM, Israel, Sept. 19, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Itay Vago, the Company's Chief Financial Officer, has decided to leave the Company for personal reasons. Current plans call for Mr. Vago to continue to serve as CFO until the publication of the Q3 2023 results. 

TORONTO and GLIL YAM, Israel, Sept. 19, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Itay Vago, the Company's Chief Financial Officer, has decided to leave the Company for personal reasons. Current plans call for Mr. Vago to continue to serve as CFO until the publication of the Q3 2023 results. 

IMC remains singularly focused on accelerating the path to profitability through active cost management and margin improvement while maintaining sales.

The Israeli ministry of health announced the anticipated medical cannabis regulatory reform on Monday August 7, 2023. The new regulations will remove many of the heavy regulations in the sector, making medical cannabis more accessible to patients as well as boosting export.

TORONTO and GLIL YAM, Israel, Aug. 8, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended June 30, 2023, on Monday, August 14, 2023 before the market opens.

TORONTO and GLIL YAM, Israel, Aug. 4, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that the Company received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") on August 1, 2023, that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on Nasdaq.

TORONTO and GLIL YAM, Israel, June 13, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on June 12, 2023, it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). IMC is now in compliance with all applicable listing standards and will continue to be

TORONTO and GLIL YAM, Israel, June 13, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on June 12, 2023, it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). IMC is now in compliance with all applicable listing standards and will continue

IMC leans further into its strategy, continuing to focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets, while accelerating its path to profitability through active cost management and margin improvement.

IMC leans further into its strategy, continuing to focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets, while accelerating its path to profitability through active cost management and margin improvement.

TORONTO and GLIL YAM, Israel, May 8, 2023 /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023 before the market opens.

TORONTO and GLIL YAM, Israel, May 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023 before the market opens.

TORONTO and GLIL YAM, Israel, May 8, 2023 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is announcing that it has closed the previously announced securities for debt settlement transaction (the "Debt Settlement") with L5 Capital Inc. ("L5 Capital"), a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company settled outstanding indebtedness of $838,776 (approximately US$615,615) through issuing 492,492 units (the "Units") at

TORONTO and GLIL YAM, Israel, May 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is announcing that it has closed the previously announced securities for debt settlement transaction (the "Debt Settlement") with L5 Capital Inc. ("L5 Capital"), a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company settled outstanding indebtedness of $838,776 (approximately US$615,615) through issuing 492,492 units (the "Uni

TORONTO and GLIL YAM, Israel, April 28, 2023 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, has agreed to a securities for debt settlement transaction (the "Debt Settlement") with L5 Capital Inc. ("L5 Capital"), a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company.  Pursuant to the Debt Settlement, the Company will settle outstanding indebtedness of $838,776 (approximately US$615,615, using the Bank of Canada daily exchange rate for April 26, 2023) through the iss

TORONTO and GLIL YAM, Israel, April 28, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, has agreed to a securities for debt settlement transaction (the "Debt Settlement") with L5 Capital Inc. ("L5 Capital"), a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company.  Pursuant to the Debt Settlement, the Company will settle outstanding indebtedness of $838,776 (approximately US$615,615, using the Bank of Canada daily exchange rate for April 26, 2023) through

TORONTO and GLIL YAM, Israel, April 14, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that the Company received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") on April 10, 2023, that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on Nasdaq.

Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively managing costs and margins

TORONTO and GLIL YAM, Israel, March 15, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022 on Wednesday, March 29, 2023, before the market opens.

The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings

The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings

TORONTO and GLIL YAM, Israel , Feb. 13, 2023 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, provides an update on its previously announced transaction with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., part of the Panaxia Labs Israel, Ltd. group of companies, (collectively, "Panaxia"). Under the transaction terms, the Company purchased the home-delivery services and an online retail footprint operating under the name "Panaxia-to-the-Home" in Israel, which includes a customer service center

TORONTO and GLIL YAM, Israel , Feb. 13, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, provides an update on its previously announced transaction with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., part of the Panaxia Labs Israel, Ltd. group of companies, (collectively, "Panaxia"). Under the transaction terms, the Company purchased the home-delivery services and an online retail footprint operating under the name "Panaxia-to-the-Home" in Israel, which includes a customer service

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO and GLIL YAM, Israel, Jan. 31, 2023 /CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce that it has closed a third tranche of its previously announced non-brokered private placement offering of units of the Company (each a "Unit") pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions (the "LIFE Offering"). An aggregate of 1,162,000 Units at a price of US$1.25 per Unit for aggregate gross proceeds of US$1,452,500 were issued and

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO and GLIL YAM, Israel, Jan. 17, 2023 /CNW/ -- Oren Shuster (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE: IMCC) (NASDAQ: IMCC), announces that he has acquired an aggregate of 856,704 common shares in the capital of the Company ("Common Shares") and 856,704 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering").

TORONTO and GLIL YAM, Israel, Jan. 17, 2023 /CNW/ -- Rafael Gabay (the "Acquiror"), CEO, director and founder of IM Cannabis Corp. ("IMCC" or the "Company") (CSE: IMCC) (NASDAQ: IMCC), announces that he has acquired an aggregate of 303,295 common shares in the capital of the Company ("Common Shares") and 303,295 Warrants (as hereinafter defined) pursuant to a non-brokered private placement offering of units ("Units") of the Company (the "Offering").

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

GLIL YAM, Israel, Nov. 17, 2022 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced today that  further to the press release dated November 14, 2022, all of its issued and outstanding common shares ("Common Shares") began trading on the Canadian Securities Exchange (the "CSE") and the Nasdaq Capital Market ("NASDAQ") on a post-consolidation basis on November 17, 2022.

Toronto, Ontario--(Newsfile Corp. - Le 15 novembre/November 2022) - IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.

Company to refocus resources and efforts on the Israeli and German markets; Commences exit of the Canadian market

The company will focus its efforts and resources on growth in Israel and Germany, with a primary focus of achieving profitability in 2023

TORONTO and GLIL YAM, Israel, Nov. 1, 2022 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022 before market opens.

Recognition highlights IMC's growing market momentum in Israel following the Company's recent streamlining initiatives

KELOWNA, BC and GLIL YAM, ISRAEL / ACCESSWIRE / October 12, 2022 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company") and IM Cannabis Corp. ("IMC") (CSE:IMCC)(NASDAQ:IMCC), jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting IMC the exclusive right to launch the BLKMKT bran

KELOWNA, British Columbia and GLIL YAM, Israel, Oct. 12, 2022 /PRNewswire/ -- Avant Brands Inc. (TSX: AVNT) (OTC-QX: AVTBF) (FRA: 1BU0) ("Avant" or the "Company") and IM Cannabis Corp. ("IMC") (CSE: IMCC) (NASDAQ: IMCC) jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting IMC the exclusive right to launch the BLKMKT brand in the Israeli medical cannabis market. The Licensing Agreement constitutes a significant milestone in the maturing and mutually beneficial relationship between the two premium cannabis companies in the Canadian

Marc Lustig, Executive Chairman of the Company Subscribes for 1,112,504 common shares at USD$0.50

CALGARY, AB and GLIL YAM, Israel, Sept. 15, 2022 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company"), Canada's largest regulated products platform, and IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) ("IMC"), today announced that SNDL has completed its initial international export of approximately 167 kilograms of premium dried flower from Canada to Israel as part of its total commitment with IMC. SNDL and IMC have agreed to the aggregate export of 1,000 kilograms of high-quality dried flower products for processing and distribution in the Israeli medical cannabis market.

CALGARY, Alberta and GLIL YAM, Israel , Sept. 15, 2022 /PRNewswire/ -- SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company"), Canada's largest regulated products platform, and IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IMC"), today announced that SNDL has completed its initial international export of approximately 167 kilograms of premium dried flower from Canada to Israel as part of its total commitment with IMC. SNDL and IMC have agreed to the aggregate export of 1,000 kilograms of high-quality dried flower products for processing and distribution in the Israeli medical cannabis market.

CALGARY, AB and GLIL YAM, Israel, Sept. 15, 2022 /PRNewswire/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company"), Canada's largest regulated products platform, and IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) ("IMC"), today announced that SNDL has completed its initial international export of approximately 167 kilograms of premium dried flower from Canada to Israel as part of its total commitment with IMC. SNDL and IMC have agreed to the aggregate export of 1,000 kilograms of high-quality dried flower products for processing and distribution in the Israeli medical cannabis market.

Einat Zakariya and Moti Marcus join the Board

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) herein announces its financial and operational results for the fourth quarter and fiscal year ended December 31, 2021. All financial information in this news release is...

TORONTO and GLIL YAM, Israel, March 10, 2022 /PRNewswire/ -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, provided preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021. All amounts are reported in Canadian dollars unless otherwise stated.

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.

The successful import demonstrates the strength of the IM Cannabis global supply chain and business model

The Flowr Corporation (“Flowr” or the “Company”) (TSXV: FLWR, OTC: FLWPF) is pleased to announce that it has completed its first shipment from Canada to Israel, as part of the previously announced international supply agreement (the “Supply...

Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.

IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market

Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million

IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the fourth installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading centre with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd.,

Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the third installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., p

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, provides details of the shares issued as part of the share consideration paid in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading center IMC-GDP license from Panaxia Ph

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 11:30 AM ET on Wednesday, September 8th.  

The Flowr Corporation (“Flowr” or the “Company”) (TSXV: FLWR, OTC: FLWPF) is pleased to provide an operational update on its Canadian and European operations and a renewed focus to maintaining its status as a premium cannabis producer and making...

Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the signing of a binding letter of intent (the "Binding LOI") with cbdMD, Inc. (YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the "Meeting").

TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the acquisition of the outstanding ordinary shares of R.A. Yarok Pharm Ltd. ("Pharm Yarok"), Rosen High Way Ltd. ("Rosen High Way"

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces the completion of a new, state-of-the-art logistics centre in Germany (the "Logistics Centre") that will allow Adjupharm GmbH ("Adjupharm"), the Company's fully licensed EU-GMP subsidiary, to internally manage a

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide a business, legal and regulatory update on its operations in Germany and Israel.

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, and MYM Nutraceuticals Inc. ("MYM"), a Canadian cultivator, processor, and distributor of premium cannabis, are pleased to announce, further to IMC's press release on July 6, 2021, the closing of IMC's acquisition of MYM Nutraceuticals Inc. ("MYM") (CSE:MYM), pre

Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 7, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has signed a multi-year supply agreement with The Flowr Corporation ("Flowr") (TSX.V:FLWR, OTC:FLWPF), a Canadian licensed producer of ultra-premium adult-use recreational and medical cannabis

The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that it has entered into a supply agreement (“Supply Agreement”) with Focus Medical Herbs Ltd. (“Focus Medical”), a company which IM Cannabis Corp....

Launches WAGNERS brand with new cultivars and SKUs

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 17, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce its unaudited financial results for the first quarter ended March 31, 2021. All figures are expressed in Canadian dollars unless otherwise indicated.

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 10, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE: IMCC), (NASDAQ: IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its previously announced overnight marketed offering (the "Offering") of 6,086,956 common shares of the Company (each an "Offered Share") at a price of US$5.75 per Offered Share for aggregate gross

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that is has entered into a best-efforts agency agreement (the "Agency Agreement") in connection with its previously announced overnight marketed offering (the "Offering") of common shares of the Company (e

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 4, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that it has commenced an overnight marketed offering (the "Offering") of the Company's common shares (each an "Offered Share") on a best-efforts agency basis. The Company may also issue to purchasers of Offered Shares, for no

With Israel's Fast-Paced E-Commerce Adoption and Cannabis Market's High Growth Rate (Averaging 4 Percent1 per Month), Panaxia's Online Platform to Support Patient Base Expansion

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce its financial results for the fourth quarter and financial year ended December 31, 2020.

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company"), is pleased to announce that it has received additional voting support agreements in connection with the proposed merger with IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) ("IMCC") which was announced on April 1, 2021 (the "Transaction"). The total of voting support agreements for the Transaction has grown to 44.4% of all votes, or 162.7 million shares, an increase from 41.7% on April 1,, 2021. A total of 66 & 2/3rds of all common and exchangeable shares voted is required to approve the Transaction as well as a majority of the minority vote in accordance with Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions.

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"), recently signed a supply agreement (the "Supply Agreement") with MediPharm Labs Australia Pty Ltd, a subsidiary of MediPharm Labs Corp. ("MediPharm Labs") (TSX:LABS), (OTCQX:M

TORONTO, ON, BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 12, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, today provided a corporate update on its operations in Germany, including the expansion of its product portfolio following the signing of a new supply agreement.

Toronto, Ontario and Vancouver, British Columbia and Glil Yam, Israel--(Newsfile Corp. - April 1, 2021) - IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) (the "Company" or "IMC"), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") to acquire MYM Nutraceuticals Inc. ("MYM") and its licensed producer subsidiary Highland Grow Inc. ("Highland Grow"), pursuant to a plan of arrangement to be completed under the Business Corporations Act (British Columbia) (the "Transaction"). The Transaction reinforces the Company's strategy as a leading global premium cannabis producer and purveyor. Following completion of the Transaction, expected to occur before the end of the second half of 2021, IMC will continue to operate under the IM Cannabis Corp. name with its common shares trading on the NASDAQ Capital Market and Canadian Securities Exchange under the ticker symbol "IMCC".

VANCOUVER, BC, April 1, 2021 /CNW/ - Trading resumes in:

TORONTO, ON, VANCOUVER, BC, and GLIL YAM, ISRAEL / ACCESSWIRE / April 1, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") to acquire MYM Nutraceuticals Inc. ("MYM") and its licensed producer subsidiary Highland Grow Inc. ("Highland Gro

VANCOUVER, BC, April 1, 2021 /CNW/ - The following issues have been halted by IIROC:

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 31, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC)( NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that it has filed a final short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada and a corresponding shelf registrat

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 18, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its acquisition of Trichome Financial Corp. ("Trichome"), previously announced on December 30, 2020 (the "Transaction"). The Transaction was completed pursuant a plan of arrangement under the Business Corporations Act

TORONTO, ON & GLIL YAM, ISRAEL / ACCESSWIRE / March 12, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada, and will file a corresponding shelf registration statement on Form F-10 (the

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 8, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), with which IMC has exclusive agreements to distribute production under the IMC brand, has signed a multi-year supply agreement with GTEC Holdings Ltd. ("GTEC") (GTEC, GGTTF, 1BUP), a Canadian license

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 1, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company's common shares (the "Common Shares") will commence trading today on the NASDAQ Capital Market ("NASDAQ") under the ticker symbol "IMCC". IMC will be the first Israeli medical cannabis operator to list its shares on NASDAQ. The Company'

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 25, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company's application to list its common shares on the NASDAQ Capital Market ("NASDAQ") has been approved. The Company's common shares (the "Common Shares") are expected to begin trading on NASDAQ under the ticker symbol "IMCC" on M

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 22, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that it has appointed Brian Schinderle and Haleli Barath to its board of directors (the "Board"). Both Mr. Schinderle and Ms. Barath are independent directors under applicable Canadian and United States securities laws.

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 16, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, today announced that further to its press releases dated December 17, 2020 and February 10, 2021, all of its issued and outstanding common shares ("Common Shares") began trading on a post-consolidation basis on February 12, 2021.

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / February 10, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that, further to its press release dated December 17, 2020, it will be consolidating all of its issued and outstanding common shares ("Common Shares") on the basis of one (1) post-consolidation Common Share for each four (4) pre-consolidation Common Shares (t

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 26, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company has received confirmation from The Depository Trust Company ("DTC") that its common shares ("Common Shares") are now eligible for electronic clearing and settlement through DTC in the United States. DTC eligibility is another

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 12, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to release a message from its Chief Executive Officer, Oren Shuster.

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 30, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, and Trichome Financial Corp. ("Trichome") (CSE:TFC), are pleased to announce that they have entered into a definitive agreement (the "Arrangement Agreement") to combine their businesses into a global leader in adult-use recreational and medical cannabis (together, the "

VANCOUVER, BC, Dec. 30, 2020 /CNW/ - Trading resumes in:

VANCOUVER, BC, Dec. 30, 2020 /CNW/ - The following issues have been halted by IIROC:

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 17, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that shareholders approved all of the motions put forward at its special meeting of shareholders (the "Special Meeting") held yesterday, which included a motion authorizing a share consolidation (the "Share Consolidation") of the Compan

* Currency is in CAD$ unless specified otherwise

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 16, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that an Israeli government committee responsible for advancing cannabis market reform published a report concluding that it supports and recommends the legalization of adult-use recreational cannabis in the State of Israel (the "Report"). Based on the Report, the Israeli Ministry of Justice is exp

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 8, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that it has applied to list its common shares (the "Common Shares") on the NASDAQ Capital Market ("NASDAQ") under the trading symbol "IMCC". The Common Shares of the Company will continue to be listed on the Canadian Securities Exchange under the same trading sym

* Currency is in CAD$ unless specified otherwise

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 6, 2020 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and across Europe, is pleased to announce that the Israeli Ministry of Health has launched a new pilot program in which medical cannabis producers will be authorized to export medical cannabis, subject to making certain products available to patients in Israel at a fixed price of NIS14 per gram (CAD$5.50 per gram) and NIS10 (CAD$4.00 per gram) for pa

IMC has now completed shipments of its branded flower products to four of the Company's ten distribution partners, marking IMC's official brand launch in Germany Three additional purchase commitments executed with German distributors IMC now has binding purchase commitments for 1,615kg of medical cannabis* Currency is in CAD$ unless specified otherwise

First shipment received into Germany from EU-GMP supply partner, allowing the Company to begin fulfilling purchase commitments for IMC-branded products Adjupharm adds Cansativa, Ilios and Farmako to its distribution network, platform now includes ten distributors* Currency is in CAD$ unless specified otherwise

Consolidated revenue increased to $3.8 million in Q2 2020, from $2.3 million in the prior year, a 62% increase, and a 180% increase over Q1 2020 Gross margin before fair value impacts was 54% in Q2 2020 Q2 2020 milestones include: Six pharmacy sales agreements signed by Focus Medical to sell IMC-branded medical cannabis in Israel Execution of German distribution platform with seven binding sales commitments signed First imports from Spain and Canada into Israel by Focus Medical Gross proceeds of approximately $6.0 million from the exercise of warrants and broker compensation options* Currenc

Focus Medical has entered into a supply agreement with Israeli-based Ever Green for a potential term of up to ten years Focus Medical will purchase all medical cannabis produced by Ever Green from its 86,000 square foot facility in Moshav Sgula, Israel Supply is secured for the six previously announced binding sales agreements between Focus Medical and pharmacies in Israel, in which the Israeli pharmacies have agreed to purchase 33,075kg of IMC-branded medical cannabis over the next three years TORONTO and GLIL YAM, Israel, July 27, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (C

IMC continues execution of German strategy with seven distribution agreements signed, adding axicorp, canymed and Materia Now a total of 1,525kg of sales secured under binding purchase commitments in Germany in the next twelve months All products to be sold under the IMC brand* Currency is in CAD$ unless specified otherwise

IMC delivering on German strategy with fourth binding purchase commitment with distribution partner in Germany Zur Rose Pharma GmbH is part of the Zur Rose Group – Europe's largest e-commerce pharmacy* Currency is in CAD$ unless specified otherwise

IMC has bolstered the network of pharmacies, distributors and supply partners that are supporting the IMC brand in both Israel and Germany Decriminalization legislation in Israel to significantly increase market potential Formal launch of IMC brand in Germany expected in Q3 2020 Recent warrant exercise adds $6.0 million to treasury, IMC fully funded for existing growth initiatives* Currency is in CAD$ unless specified otherwise

Adds $6.0 million to treasury, IMC fully funded for existing growth initiatives* Currency is in CAD$ unless specified otherwise

Peer-reviewed study indicates two IMC branded medical cannabis strains were effective in reducing migraines in over 60% of treated patients Study conducted by Professor Dedi Meiri of Technion - Israeli Institute of Technology IMC continues to pursue evidence-based research for medical applications of cannabis TORONTO and GLIL YAM, Israel, June 24, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, announced today that a recent peer-reviewed study conducted by Professor Dedi

Decriminalization framework passes first reading with Ministerial Committee on Legislation IMC in market leading position in Israel to benefit from cannabis reforms and larger market TORONTO and GLIL YAM, Israel, June 22, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that the Israeli government has advanced legislation for the decriminalization of cannabis. Yesterday, June 21, the Ministerial Committee on Legislation approved a bill for the decr

Strong relationships with Canadian medical cannabis industry are a strategic imperative to IMC as a global medical cannabis brand Focus Medical has successfully imported approximately 200kg of medical cannabis from Canada, now seven suppliers cultivating under IMC brand across Israel, Spain and Canada IMC brand well positioned for Israeli government decriminalization reforms* Currency is in CAD$ unless specified otherwise

New generation of evidence-based cannabis products to be launched in Israel IMC to be exclusive distributor of CannEpil® in Israel for five-year term CannEpil® was developed by MGC Pharma for the treatment of refractory epilepsy* Currency is in CAD$ unless specified otherwise

TORONTO and GLIL YAM, Israel, June 10, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to express its support for the Israeli government's plans to advance legislation on non-discrimination between medical and recreational cannabis users.

Focus Medical has now entered into pharmacy sales agreements in Israel to deliver $193.5 million of medical cannabis over the next three years at an expected gross margin of 50% All supply for the pharmacy sales agreements has been secured, including initial shipments from Spain into Israel Momentum in revenue is expected to increase in Q2/2020 and gradually throughout the balance of the year* Currency is in CAD$ unless specified otherwise

Focus Medical recently completed a semi-annual record harvest of over 3,000kg of medical cannabis Focus Medical's first two months of shipments of IMC-branded medical cannabis products to Super-Pharm and Panaxia totalled over 250kg Approximately 450kg of medical cannabis is expected for shipment in Q2 2020 under sales agreements with Super-pharm and Panaxia and 2,550kg of medical cannabis is expected for shipment in the latter half of 2020 under previously announced pharmacy sales agreements * Currency is in CAD$ unless specified otherwise

TORONTO and GLIL YAM, Israel, May 27, 2020  /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) announces that filing of the Company's interim financial statements for the three month period ended March 31, 2020 (the "Q1 Financial Statements") and associated management's discussion and analysis (the "Q1 MD&A", and collectively with the Q1 Financial Statements, the "Q1 Filings") will be postponed due to delays caused by the COVID-19 pandemic.

Focus Medical has successfully imported approximately 200kg of medical cannabis from Spain into Israel The medical cannabis was supplied by Linneo Health, the Company's strategic supply partner in Spain and an EU-GMP global supplier of medicinal cannabis Six suppliers now cultivating medical cannabis to Focus Medical for sale under the IMC brand in Israel* Currency is in CAD$ unless specified otherwise

IMC's EU-GMP licensed subsidiary, Adjupharm, has been approved to import 4,000kg of medical cannabis into Germany from additional foreign suppliers pursuant to a license extension granted by BfArMThe License includes the ability to import flower and extracts from several countries, approved for both bulk and primary productsThe License allows all sales currently under binding commitment in Germany to be fulfilled from abroad TORONTO, GLIL YAM, Israel and BAD OLDESLOE, Germany, May 19, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical c

Israeli Ministry of Economy signed a Free Export Order for medical cannabis productsGovernment to begin accepting medical cannabis export applications in 30 daysNew export order significantly increases international market potential for the IMC brand TORONTO and GLIL YAM, Israel, May 14, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that the Israeli Ministry of Economy signed a Free Export Order for medical cannabis products on May 13, 2020. In 3

Executing on long-term strategy to build distribution platform across the large German marketSales commitment for 465kg of IMC-branded medical cannabis over the next twelve months Together with other announced binding purchase agreements in Germany, a total of 825kg of IMC-branded medical cannabis is committed for sale over the next twelve months *Currency is in CAD$ unless specified otherwise

First step in a long-term strategy to develop a network of distribution partners in order to maximize brand awareness among physicians, pharmacists and patients in Germany IMC's distribution subsidiary in Germany will deliver a total of 360kg of medical cannabis to two distributors in Germany beginning in June 2020 All medical cannabis sold to these distributors under the IMC brand * Currency is in CAD$ unless specified otherwise

Focus Medical has entered into a supply agreement to purchase up to a total 8,060kg of medical cannabis between 2020 and 2023 Focus Medical has now secured all the supply required under the six binding pharmacy sales agreements it has signed In 2020, Focus Medical signed binding sales agreements for pharmacies to purchase 33,075kg in medical cannabis under the IMC brand, revenue of CAD$193.5 million to IMC over the next three years, at an expected gross margin of 50% TORONTO and GLIL YAM, Israel, April 27, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world

VANCOUVER, April 21, 2020 /CNW/ - Trading resumes in:

VANCOUVER, April 21, 2020 /CNW/ - The following issues have been halted by IIROC:

Consolidated revenues increased 72% to $2.5 million in Q4 2019, fiscal 2019 consolidated revenue increased 75% with a gross margin of 48% Strong financial position at December 31, 2019 with $13.9 million in cash, $21.7 million in working capital and no debt Sales agreements for $121.9 million in consolidated revenue to IMC over three years signed by Focus Medical subsequent to year-end*

Focus Medical has entered into two additional binding sales agreements: Max Pharm for up to 1,500kg over three years and Panaxia for 1,000kg of medical cannabis under the IMC brand Max Pharm adds IMC-branded products to its retail pharmacy and home delivery platform, and Panaxia will launch IMC products across the largest home delivery platform in Israel In 2020, Focus Medical has signed binding sales agreements to supply 20,475kg in medical cannabis under the IMC brand – totalling up to CAD$121.9 million in revenue to IMC over the next three years, at an expected gross margin of 50% TORON

VANCOUVER, April 13, 2020 /CNW/ - Trading resumes in:

Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel's largest pharmacy chain, for 13,575kg of IMC branded medical cannabis productsSales to begin in April 2020 through Super-Pharm's omnichannel distribution network including 41 pharmacies licensed to sell medical cannabis, as well as home delivery and e-commerce platformsTo date in 2020, Focus Medical has signed binding sales agreements for 17,975kg of medical cannabis products with a value of CAD$107.4 million in revenue expected over the next three years TORONTO and GLIL YAM, ISRAEL, April 13, 202

VANCOUVER, April 13, 2020 /CNW/ - The following issues have been halted by IIROC:

Focus Medical, entered into a two-year binding agreement to sell 1,000kg of medical cannabis a year to Shor Tabachnik pharmacies The two-year contract is valued at approximately CAD$12 million; now 4,400kg for an approximate value of CAD$27 million contracted over next three years All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, Israel, April 8, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce

Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased...

Israeli and German operations continue to advance strategic priorities, investments into innovation will be deferred Israeli operation to benefit from two supply agreements and one sales agreement recently signed by Focus Medical IM Cannabis currently has CAD$11.8 million in cash and no debt TORONTO and GLIL YAM, Israel, April 2, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to provide a business update to the investment community regarding the COVID-19 pand

IMC continues to build asset-light business model to satisfy rising demand for medical cannabis in Israel with supply of approximately 2,600kg of medical cannabis per year using Focus Medical's proprietary genetics All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 31, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), a licensed medical

Focus Medical entered into a binding agreement to sell 800kg of medical cannabis a year to a group of pharmacies in Jerusalem over a period of three years Total contract value of approximately CAD$15 million All medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, ISRAEL, March 30, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical"), a licensed medical cannab

Intelicanna, an Israeli cannabis company traded on the Tel Aviv Stock Exchange under the ticker symbol "INTL", to supply a minimum of 500kg and up to 1,000kg of medical cannabis to Focus Medical using Focus Medical's proprietary geneticsAll medical cannabis sold according to this agreement will be under the IMC brand TORONTO and GLIL YAM, Israel, March 23, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medica

TORONTO and GLIL YAM, Israel, March 17, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC) is pleased to announce that at the annual general meeting of shareholders of the Company (the "Meeting") held earlier today, the shareholders elected Oren Shuster, Marc Lustig, Steven Mintz, Rafael Gabay and Vivian Bercovici as directors of the Company. Incumbent director Jesse Kaplan did not seek re-election at the Meeting and Rafael Gabay and Vivian Bercovici were elected to the board of directors (the "Board") for the first time. The Board would like to thank Mr. Kaplan for his serv

TORONTO and GLIL YAM, Israel, Jan. 30, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is preparing for the expansion of medical cannabis export from Israel in light of the recent news about government approval and the completion of the first medical cannabis shipment from Israel to the United Kingdom.

IMC to become 25% Joint Venture partner for cultivation and processing operation in Greece Preferred supply agreement to diversify sources of EU-GMP medical cannabis for export to Germany and other emerging markets TORONTO and GLIL YAM, Israel, Jan. 28, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is pleased to announce that on January 23, 2020 it signed definitive agreements to establish a medical cannabis cultivation and processing joint venture in Greece (the "Jo

TORONTO and GLIL YAM, Israel, Jan. 7, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe, is pleased to announce that it has invested in a unique biosynthesis technology by entering into a share purchase agreement dated December 26, 2019 with Xinteza API Ltd. ("Xinteza") whereby the Company will acquire 25% of Xinteza's outstanding common shares for consideration of up to US$1.7 million. IMC's investment will be funded with existing cash resources.

TORONTO and GLIL YAM, Israel, Jan. 6, 2020 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering and innovation focused medical cannabis companies with operations in Israel and across Europe, is pleased to release a message from its Chief Executive Officer, Oren Shuster.

TORONTO and GLIL YAM, Israel, Dec. 18, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations in Israel and across Europe, is providing an update on an interim order recently issued by the Israeli High Court of Justice (the "High Court") (the "Interim Order") requiring medical cannabis cultivators and production companies in Israel to extend the supply of medical cannabis to certain patients who, under the former regulatory regime, were licensed to receive medical cannabis until July 30, 2019, as per condi

Mr. Berger brings over 10 years of experience in managing large-scale operations in the government and private sectors including as the head of a leading telemedicine and pharmaceutical distribution company Mr. Berger established Greenpharma, one of Israel's first online pharmacies focused on medical cannabis patients Oren Shuster to remain CEO of IM Cannabis Corp. TORONTO and GLIL YAM, Israel, Dec. 6, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMCC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations across Europe, is pleased to announce the appoin

IM Cannabis Corp. invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation TORONTO and GLIL YAM, Israel, Dec. 4, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that Oren Shuster, Chief Executive Officer, will present live at Grit Capital's Webcast Series on December 10, 2019 at 11:00am ET/8:00am PT.

Consolidated revenues increased 70% to $2.3 million as sales volume and patient count continue to increase compared to previous year Focus increased its active registered patients by 28% to 4,636 as IMC-branded products maintain a leadership position in Israel Navasota completed private placement for gross proceeds of $20.4 million to fund the Company's Europe-focused growth strategy* Currency is in Canadian dollars unless specified otherwise.

TORONTO and GLIL YAM, Israel, Nov. 21, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE: IMCC), one of the world's pioneering medical cannabis companies with operations across Europe, is pleased to announce that 9,730,258 warrants of the Company (the "Warrants") have begun trading on the Canadian Securities Exchange (the "CSE") under the trading symbol "IMCC.WT". Each Warrant, entitles the holder thereof to purchase one common share in the capital of the Company at an exercise price of $1.30 until October 11, 2021. 

TORONTO and GLIL YAM, Israel, Nov. 18, 2019 /CNW/ - IM Cannabis Corp. (formerly Navasota Resources Inc.) (the "Company" or "IMC") (CSE: IMCC) has applied to list 9,730,258 warrants of the Company (the "Warrants") for trading on the Canadian Securities Exchange (the "CSE"). The Warrants had previously been issued pursuant to the terms of a private placement offering of subscription receipts by a wholly owned subsidiary of the Company that was partially brokered by a syndicate of agents led by Cormark Securities Inc. and comprised of Canaccord Genuity Corp., First Republic Capital Corp., Haywo

TORONTO and GLIL YAM, Israel, Nov. 12, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that it will be presenting at the PI Financial Cannabis Conference in London, England on November 18, 2019.

IM Cannabis becomes third Israeli cannabis listing in past six weeks

IMC is the first Israeli medical cannabis company to list its shares in Canada and will trade under the ticker "IMCC" on the Canadian Securities ExchangeThe Company recently completed a private placement for gross proceeds of over CAD$20 million to bolster its footprint across Europe, including Germany, Portugal and GreeceInitial shipment from the EU-GMP facility in Europe to Germany is expected in Q2 2020 TORONTO and GLIL YAM, Israel, Nov. 5, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC"), one of the world's pioneering medical cannabis companies with operations across Europe,  is